论文部分内容阅读
地中海贫血是一种遗传性溶血性贫血,目前尚无特效疗法,对某些病例进行选择性脾切除治疗,对改善贫血、减少输血有一定效果。有些作者观察到地中海贫血患儿,在脾切除后容易并发感染。为了探讨易发感染的原因,最近,我们观察了26例地中海贫血脾切除后细胞与体液免疫若干指标,并与15例未切除脾的地中海贫血患儿作为对照,发现在脾切除后细胞免疫指标有一定的变化,现小结如下:
Thalassemia is a hereditary hemolytic anemia, there is no specific treatment, selective splenectomy in some cases of treatment, to improve anemia, reduce blood transfusion have a certain effect. Some authors have observed that children with thalassemia are more likely to contract infection after splenectomy. In order to explore the reasons for the susceptibility to infection, we recently observed a number of indicators of cell and humoral immunity after splenectomy in 26 cases of thalassemia and compared with 15 cases of children with thalassemia without splenectomy and found that after splenectomy the cellular immunity index A certain change, are summarized as follows: